February 17, 2013
Briefly
- Reconstructing the path of the Chelyabinsk meteorite in Google Earth
- Researchers analysing internet commerce randomized trials (re)discover and solve a lot of problems in experimental design (via both Ben Goldacre and Andrew Gelman)
- From Nature News: stem-cell research in Texas. The company is outraged by “FDA’s decision to regulate your own stem cells as a drug”. That’s FDA requiring safe manufacturing — the company hasn’t even started clinical trials yet.
- 80 patient groups sign up to the AllTrials campaign.
Thomas Lumley (@tslumley) is Professor of Biostatistics at the University of Auckland. His research interests include semiparametric models, survey sampling, statistical computing, foundations of statistics, and whatever methodological problems his medical collaborators come up with. He also blogs at Biased and Inefficient See all posts by Thomas Lumley »